Eosinophilic Granuloma D004803

Related MeSH Hierarchy (5)

Diseases [C] » Musculoskeletal Diseases [C05] » Bone Diseases » Eosinophilic Granuloma

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Leukocyte Disorders » Eosinophilia » Eosinophilic Granuloma

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Lymphatic Diseases » Histiocytosis » Histiocytosis, Langerhans-Cell » Eosinophilic Granuloma

Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Granuloma » Eosinophilic Granuloma

Description

The most benign and common form of Langerhans-cell histiocytosis which involves localized nodular lesions predominantly of the bones but also of the gastric mucosa, small intestine, lungs, or skin, with infiltration by EOSINOPHILS.   MeSH

Phase 4 Indicated Drugs (1)

Phase 2 Indicated Drugs (2)

Other Experimental Indicated Drugs (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.